MetLife (MET) Q3 2026 Earnings Call Transcript

MetLife (MET) reported Q3 2026 adjusted earnings of $1.8B ($2.85 EPS), up 17% YoY. Adjusted EPS ex-items rose 22%, with ROE at 19.6%. Growth was driven by Group Benefits, Retirement & Income Solutions, and Asia. The company repurchased $650M in shares, bringing YTD capital return to $3.5B.

Original reporting
Published Nov 5, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MetLife (MET) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$METBullishHigh
01

Why it matters

The strong earnings growth and capital return signal robust profitability, likely prompting investors to increase exposure to MetLife and related insurers.

02

Market read

First‑report earnings with double‑digit growth and a sizable buyback make this a high‑impact news item for equity traders.

03

What to watch

Higher expense ratio from the PineBridge acquisition may limit near‑term margin expansion despite earnings growth.

Relevance 9/10Novelty 9/10Timing: after‑hours release today

Background

MetLife's Q3 2026 earnings call provides the first public disclosure of its quarterly performance, including adjusted EPS, segment results, and a $915 million share repurchase program.

Company-level read

Ticker impact

$METBullishHigh confidence
Context

MetLife reported Q3 2026 adjusted earnings of $2.85 per share, up 22% YoY, and announced a $915 million share repurchase, indicating strong performance.

Expected impact

likely upward pressure as the market prices in the earnings beat and buyback tranche

Evidence & confidence

Large‑cap insurer with double‑digit earnings growth and a multi‑hundred‑million share repurchase typically drives a positive price reaction.

Market effects

Life‑insurance sector may see broader optimism as MetLife's results highlight strong underwriting margins and AI‑driven cost efficiencies.

U.S. market sentiment likely improves, especially for financials and insurers.

MetLife's global footprint means the earnings beat could lift sentiment for multinational insurers worldwide.

Counterpoint

If the market has already priced in the earnings beat, the stock could face short‑term profit‑taking.

Key entities

  • MetLife

    U.S.-listed life insurance and financial services provider (ticker MET).

Related articles

$METHighAI 8/10

MetLife Q3 Earnings Call Highlights

MetLife reported Q3 earnings, with variable investment income of $1.5B for the first nine months, on track to exceed its $1.6B full-year guidance. Group Benefits and Retirement adjusted earnings rose 14% and 12% respectively. International operations saw mixed results, with Asia up 21% and Latin America down 5%. The company repurchased $650M in shares in Q3 and is on track to meet its full-year targets.

$METMedAI 8/10

Chesnara bags £1.7bn MetLife UK closed life book in latest takeover

Chesnara agreed to acquire MetLife UK's closed-book life insurance business for £1.7bn in assets, subject to regulatory approval. The deal is expected to generate £90m in lifetime cashflows, with £45m added to Own Funds and Contractual Service Margin. Chesnara aims to strengthen its UK business and future cash generation. Analysts note the deal boosts long-term capital generation without significantly impacting Chesnara's acquisition firepower.

$METMed

Chesnara To Buy MetLife's Closed-book UK Life Insurance Firm; Terms Not Disclosed

Chesnara plc (CSN.L) agreed to buy MetLife's (MET) closed-book UK life insurance unit, MetLife UK Limited, for an undisclosed sum. The deal, expected to close in early 2027, will add 18,000 policies and £1.7 billion in assets. Chesnara anticipates £45 million boost to Own Funds and Contractual Service Margin, with £90 million in lifetime cash flows, half within five years. Shares rose 1.15%.